Kontigo Care Q2’22: Strong sales and 16% EBIT margin

Research Note



Redeye comments on Kontigo Care’s Q2’22 report where sales came in slightly higher than we estimated. The company continues to impress with solid revenue growth of 23% Y/Y and 8% Q/Q. This was the 9th consecutive report with net sales growth, continuing the solid growth path.


Jessica Grunewald

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.